Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,769 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial.
Nakayama M, Nakano H, Hamada H, Itami N, Nakazawa R, Ito S. Nakayama M, et al. Nephrol Dial Transplant. 2010 Sep;25(9):3026-33. doi: 10.1093/ndt/gfq196. Epub 2010 Apr 12. Nephrol Dial Transplant. 2010. PMID: 20388631 Clinical Trial.
Plasma pteridine concentrations in patients with chronic renal failure.
Yokoyama K, Tajima M, Yoshida H, Nakayama M, Tokutome G, Sakagami H, Hosoya T. Yokoyama K, et al. Nephrol Dial Transplant. 2002 Jun;17(6):1032-6. doi: 10.1093/ndt/17.6.1032. Nephrol Dial Transplant. 2002. PMID: 12032193
The negative Ca(2+) balance is involved in the stimulation of PTH secretion.
Yokoyama K, Kagami S, Ohkido I, Kato N, Yamamoto H, Shigematsu T, Nakayama M, Fukagawa M, Kawaguchi Y, Hosoya T. Yokoyama K, et al. Nephron. 2002 Sep;92(1):86-90. doi: 10.1159/000064484. Nephron. 2002. PMID: 12187089
Multicenter survey on hydration status and control of blood pressure in Japanese CAPD patients.
Nakayama M, Kawaguchi Y; Water and Electrolyte Balance (WEB) Study Group in CAPD. Nakayama M, et al. Perit Dial Int. 2002 May-Jun;22(3):411-4. Perit Dial Int. 2002. PMID: 12227402 Clinical Trial. No abstract available.
IRMA (whole PTH) is a more useful assay for the effect of PTH on bone than the Allegro intact PTH assay in CAPD patients with low bone turnover marker.
Tanno Y, Yokoyama K, Nakayama M, Katoh A, Yamamoto H, Iwasaki Y, Cantor T, Fukagawa M, Shigematsu T, Hosoya T. Tanno Y, et al. Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii97-8. doi: 10.1093/ndt/gfg1025. Nephrol Dial Transplant. 2003. PMID: 12771313
Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
Ota K, Akiba T, Nakao T, Nakayama M, Maeba T, Park MS, Tranaeus A, Yorioka N; Icodextrin Study Group. Ota K, et al. Perit Dial Int. 2003 Jul-Aug;23(4):356-61. Perit Dial Int. 2003. PMID: 12968843 Clinical Trial.
Hyper-vascular change and formation of advanced glycation endproducts in the peritoneum caused by methylglyoxal and the effect of an anti-oxidant, sodium sulfite.
Nakayama M, Sakai A, Numata M, Hosoya T. Nakayama M, et al. Am J Nephrol. 2003 Nov-Dec;23(6):390-4. doi: 10.1159/000074065. Epub 2003 Oct 10. Am J Nephrol. 2003. PMID: 14551463
Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.
Yamamoto R, Otsuka Y, Nakayama M, Maruyama Y, Katoh N, Ikeda M, Yamamoto H, Yokoyama K, Kawaguchi Y, Matsushima M. Yamamoto R, et al. Clin Exp Nephrol. 2005 Jun;9(2):148-52. doi: 10.1007/s10157-005-0349-8. Clin Exp Nephrol. 2005. PMID: 15980950
2,769 results
Jump to page
Feedback